Can we measure 5-HT release with PET?

Can we measure 5-HT release with PET?

Bibliographic Details
Main Authors:	Grasby, P, Hirani, E, Hume, S, Cowen, P, Rabiner, E, Sharp, T
Format:	Conference item
Published:	2003

Similar Items

Effect of endogenous 5-HT on [C-11]MDL 100907 binding investigated in rat brain using PET
by: Hirani, E, et al.
Published: (2003)

Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies.
by: Hirani, E, et al.
Published: (2003)

Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635.
by: Rabiner, E, et al.
Published: (2000)

5-HT1A receptor binding in panic disorder; comparison with depressive disorder and healthy volunteers using PET and [11C]WAY-100635
by: Sargent, P, et al.
Published: (2000)

Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?
by: Rabiner, E, et al.
Published: (2004)

Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis.
by: Gartside, SE, et al.
Published: (1992)

Attenuation of preferential occupancy of 5-HT1A autoreceptors by pindolol in depressed patients: effect of SSRIs or an endophenotype of the depressed state?
by: Rabiner, E, et al.
Published: (2002)

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.
by: Turner, M, et al.
Published: (2005)

Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.
by: Gartside, SE, et al.
Published: (1992)

5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635.
by: Sargent, P, et al.
Published: (2010)

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy.
by: Rabiner, E, et al.
Published: (2000)

5-HT and depression: is the glass half-full?
by: Sharp, T, et al.
Published: (2011)

Lithium increases 5-HT-mediated prolactin release.
by: McCance, S, et al.
Published: (1989)

Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635.
by: Hirani, E, et al.
Published: (2000)

Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
by: Meyer, P, et al.
Published: (2010)

IN-VIVO EVIDENCE THAT D-FENFLURAMINE RELEASES 5-HT FROM NERVE-TERMINALS OF BOTH THE DORSAL AND MEDIAN RAPHE NUCLEI
by: Mcquade, R, et al.
Published: (1995)

Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study.
by: Le Masurier, M, et al.
Published: (2004)

In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.
by: Boothman, L, et al.
Published: (2006)

Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo.
by: Gartside, SE, et al.
Published: (1992)

EFFECT OF AMINO-ACID LOADS ON HIPPOCAMPAL 5-HT RELEASE INVITRO EVOKED BY ELECTRICAL-STIMULATION OF THE DORSAL RAPHE NUCLEUS AND D-FENFLURAMINE ADMINISTRATION
by: Gartside, S, et al.
Published: (1992)

Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressives
by: Bhagwagar, Z, et al.
Published: (2001)

p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
by: Series, H, et al.
Published: (1994)

Decreased 5-HT-mediated prolactin release in major depression.
by: Anderson, I, et al.
Published: (1992)

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.
by: Bhagwagar, Z, et al.
Published: (2004)

Human 5-HT transporter availability predicts amygdala reactivity in vivo.
by: Rhodes, R, et al.
Published: (2007)

Does metergoline selectively attenuate 5-HT mediated prolactin release?
by: Ellis, P, et al.
Published: (1991)

A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables.
by: Rabiner, E, et al.
Published: (2002)

Evidence for co-localisation of neurokinin-1 and 5-HT1A receptors in pat forebrain
by: Hafizi, S, et al.
Published: (2004)

Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients.
by: Bhagwagar, Z, et al.
Published: (2002)

Augmentation strategies: 5-HT and beyond
by: Cowen, P
Published: (2002)

Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
by: Whale, R, et al.
Published: (1999)

ENDOCRINOLOGIC RESPONSES TO 5-HT
by: Cowen, P, et al.
Published: (1990)

Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
by: Hinz, R, et al.
Published: (2007)

ABNORMAL 5-HT NEUROENDOCRINE FUNCTION IN DEPRESSION
by: Cowen, P
Published: (1990)

Psychopharmacology of 5-HT(1A) receptors.
by: Cowen, P
Published: (2000)

PSYCHOTROPIC-DRUGS AND HUMAN 5-HT NEUROENDOCRINOLOGY
by: Cowen, P
Published: (1987)

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
by: Gartside, SE, et al.
Published: (1999)

Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
by: Selvaraj, S, et al.
Published: (2011)

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
by: Glue, P, et al.
Published: (1986)

Effect of the 5-HT1A partial agonist buspirone on regional cerebral blood flow in man.
by: Grasby, P, et al.
Published: (1992)